Skip to Main Content Menu Search Site

Broad-Spectrum RNA Therapeutic for Treatment of COVID-19 and Influenza

Immunostimulatory dsRNAs inhibit infection by multiple respiratory viruses, including SARS-CoV-2 and influenza

Want to license this technology?

We are actively seeking a commercial partner with experience in RNA therapeutics and targeted delivery to help rapidly commercialize this technology.


Bioinspired Therapeutics & Diagnostics

Primary Investigator
  • Coronaviruses including SARS-CoV, SARS-CoV-2, MERS-CoV, and common cold virus NL63
  • Multiple strains of influenza A
  • Fungal, bacterial, and/or parasitic pathogens
  • Cancer
  • Autoimmune diseases
Patent Status
Close menu